U.S. Patent Office Grants Renew Biopharma Pivotal Patent for Cannabinoid Biosynthesis

SAN DIEGO–(BUSINESS WIRE)– #Cannabinoids–Renew Biopharma today announced that the United States Patent and Trademark Office (USPTO) has granted powerful patent claims on the landmark patent application (WO2019183152) relating to the rational-based engineering of a key enzyme that is most efficient for large-scale microbial cannabinoid biosynthesis (i.e. NphB). This key enzyme produces CBGA and CBG, the precursors to most cannabinoids (including THC and CBD). Renew is a pre-clinical startup drug company deve